- Investing Ideas
- Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
19
Companies which are more than 50% undervalued based on analyst price target.
19 companies
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.00
7D
0%
1Y
15.7%
Verano Holdings
Market Cap: CA$553.9m
Engages in the cannabis business in the United States.
VRNO
CA$7.60
7D
-4.4%
1Y
87.7%
Eupraxia Pharmaceuticals
Market Cap: CA$537.0m
A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.
EPRX
CA$8.74
7D
-1.0%
1Y
12.3%
Canopy Growth
Market Cap: CA$536.1m
Engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally.
WEED
CA$1.32
7D
0.8%
1Y
-13.2%
Cresco Labs
Market Cap: CA$436.0m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$0.94
7D
-6.9%
1Y
0%
Spectral Medical
Market Cap: CA$396.1m
Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.
EDT
CA$1.38
7D
-1.4%
1Y
68.3%
TerrAscend
Market Cap: CA$276.1m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.74
7D
-6.3%
1Y
19.4%
High Tide
Market Cap: CA$268.0m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.01
7D
-1.6%
1Y
-3.2%
Cardiol Therapeutics
Market Cap: CA$192.5m
A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.64
7D
-6.3%
1Y
-21.9%
Organigram Global
Market Cap: CA$185.8m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.33
7D
2.3%
1Y
-34.6%
HLS Therapeutics
Market Cap: CA$128.5m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$4.19
7D
1.9%
1Y
-15.7%
Vext Science
Market Cap: CA$60.7m
Through its subsidiaries, engages in integrated cannabis operations in the United States.
VEXT
CA$0.24
7D
-2.0%
1Y
25.6%
Decibel Cannabis
Market Cap: CA$60.6m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.11
7D
0%
1Y
15.8%
Planet 13 Holdings
Market Cap: CA$57.0m
Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.
PLTH
CA$0.17
7D
-10.8%
1Y
-45.9%
Sernova Biotherapeutics
Market Cap: CA$41.5m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.12
7D
9.1%
1Y
-41.5%
Optimi Health
Market Cap: CA$37.4m
Operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.
OPTI
CA$6.74
7D
0.1%
1Y
40.4%
Medicenna Therapeutics
Market Cap: CA$32.3m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.34
7D
-1.4%
1Y
-57.4%
Rubicon Organics
Market Cap: CA$30.4m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.45
7D
-1.1%
1Y
1.1%
Delivra Health Brands
Market Cap: CA$3.1m
Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.
DHB
CA$0.09
7D
-10.0%
1Y
-59.1%